Lenvaxen (Lenvatinib) 4 mg capsules

Lenvaxen 4mg Capsules contain Lenvatinib, a kinase inhibitor that blocks pathways involved in cancer cell growth and the formation of new blood vessels that support tumors.

Uses

Lenvatinib may be prescribed for certain cases of:

• Thyroid Cancer: Differentiated thyroid cancer that is recurrent, metastatic, progressive or resistant to radioactive iodine treatment.
• Liver Cancer: Certain cases of unresectable hepatocellular carcinoma.
• Kidney Cancer: Advanced renal cell carcinoma in combination with other medicines.
• Endometrial Cancer: Certain advanced endometrial cancers in combination with pembrolizumab.

Common Side Effects

High blood pressure, fatigue, diarrhea, decreased appetite, weight loss, nausea, vomiting, joint or muscle pain, mouth sores, headache, protein in the urine and hoarseness may occur. Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.